Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols

Leukemia and Lymphoma

Volumn 45, Issue 9, 2004, Pages 1899-1904

  Matthews, Christine ^a,b   Catherwood, Mark A ^a   Morris, T C M ^a   Alexander, H Denis ^a,b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

BIOMED 2; Chromosomal abnormalities; Chronic lymphocytic leukemia; IgVH mutational status; ZAP 70

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; PRIMER DNA; PROTEIN KINASE ZAP 70; RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DEVICE; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS; STANDARDIZATION; TREATMENT OUTCOME; TRISOMY 12; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; REFERENCE STANDARDS;

EID: 3242883817     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190410001710812     Document Type: Article

References (13)

1. Caligaris-Capio, F. and Hamblin, T.J. (1999) "B-cell lymphocytic leukaemia; a bird of a different feather", Journal of Clinical Oncology, 17, 399-408.
2. Kipps, T.J. (2000) "Chronic lymphocytic leukemia", Current Opinions in Hematology, 7, 223-234.
3. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. and Stevenson, F.K. (1999) "Unmutated IgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia", Blood, 94, 1848-1854.
4. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., et al. (1999) "IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood, 94, 1840-1847.
5. Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., et al. (2002) "V(H) mutation status, CD38 expression level, genomic abberrations, and survival in chronic lymphocytic leukaemia", Blood, 100, 1410-1416.
6. Oscier, D.G., Gardiner, A.C., Mould, S.J., Davis, Z.A., Ibbotson, R.E., Corcoran, M.M., et al. (2002) "Multivariate analysis of prognostic factors in CLL; clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors", Blood, 100, 1177-1184.
7. , Blood, 98, 129.
8. Sandberg, Y., Heule, F., Lam, K., Lugtenburg, P.J., Wolvers-Tettero, I.L.M., van Dongen, J.J.M., et al. (2003) " Molecular immunoglobulin/T cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol", Haematologica, 88, 659-670.
9. van Dongen, J.J., Langerak, A.W., Bruggemann, M., Evans, P.A., Hummel, M., Lavender, F.L., et al. (2003) "Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936", Leukemia, 17, 2257-2317.
10. H genes are inherently susceptible to amino acid replacement", Immunology Today, 15, 367-373.
11. λ 2-14 gene use and homologous CDR3s: implicating recognition of a common antigen eptiope", Blood, 101, 4952-4957.
12. Wiestner, A., Rosenwald, A., Barry, T.S., Wright, G.R., Davis, E., Henricksen, S.E., et al. (2003) "ZAP-70 expression identifies a chronic leukemia subtype with unmutated immunogloblin genes, inferior clinical outcome, and distinct gene expression profile", Blood, 101, 4944-4951.
13. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., et al. (2003) "Zap-70 expression as a surrogate for immunoglobulin variable region mutations in chronic lymphocytic leukemia", New England Journal of Medicine, 348, 1764-1775.